Iskani rezultati za avtorja

1

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays od Kathy S. Albain, Soonmyung Paik, Laura van’t Veer

Izdano 2009

Polni tekst
Revisão

Dodaj v priljubljene

Shranjeno v:
2

The MINDACT trial: The first prospective clinical validation of a genomic tool od Fátima Cardoso, Martine Piccart, Laura Van't Veer, Emiel J. Rutgers

Izdano 2007

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
3

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary od John Bridgewater, Ryan K. van Laar, Arno Floore, Laura van’t Veer

Izdano 2008

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
4

Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity od Denise M. Wolf, Marc E. Lenburg, Christina Yau, Aaron Boudreau, Laura van ‘t Veer

Izdano 2014

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
5

Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma od Patti Curl, Igor Vujic, Laura van ‘t Veer, Susana Ortiz‐Urda, James G. Kahn

Izdano 2014

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
6

TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. od Guus Hateboer, H. T. Marc Timmers, AK Rustgi, Marc Billaud, Laura van ‘t Veer, René Bernards

Izdano 1993

Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
7

E2F-5, a New E2F Family Member That Interacts with p130 In Vivo od E. Marielle Hijmans, P. Mathijs Voorhoeve, Roderick L. Beijersbergen, Laura van ‘t Veer, René Bernards

Izdano 1995

Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
8

Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability od Josien C.C. Scheepens, Laura van ‘t Veer, Laura J. Esserman, Jeffrey Belkora, Rita A. Mukhtar

Izdano 2021

Polni tekst Polni tekst
Revisão

Dodaj v priljubljene

Shranjeno v:
9

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance od Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura van ‘t Veer, Mark Jesus M. Magbanua

Izdano 2023

Polni tekst Polni tekst
Revisão

Dodaj v priljubljene

Shranjeno v:
10

Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. od Mark J. Alkema, Marieke Bronk, Els Verhoeven, Arie P. Otte, Laura van ‘t Veer, A Berns, Maarten van Lohuizen

Izdano 1997

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
11

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature od Michael Knauer, Fátima Cardoso, Jelle Wesseling, Philippe L. Bédard, Sabine C. Linn, Emiel J. Rutgers, Laura van ‘t Veer

Izdano 2010

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
12

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis od Alexandra J. van den Broek, Marjanka K. Schmidt, Laura van ‘t Veer, Rob A.�E.�M. Tollenaar, Flora E. van Leeuwen

Izdano 2015

Polni tekst Polni tekst
Revisão

Dodaj v priljubljene

Shranjeno v:
13

Comparison of prognostic gene expression signatures for breast cancer od Benjamin Haibe‐Kains, Christine Desmedt, Fanny Piette, Marc Buyse, Fátima Cardoso, Laura van’t Veer, Martine Piccart, Gianluca Bontempi, Christos Sotiriou

Izdano 2008

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
14

Expression profiling predicts outcome in breast cancer od Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver, Yudong D. He, Augustinus A. M. Hart, René Bernards, Stephen Friend

Izdano 2002

Polni tekst Polni tekst
Carta

Dodaj v priljubljene

Shranjeno v:
15

Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer od Rob Michalides, Alexander Griekspoor, Astrid Balkenende, Desirée Verwoerd, Lennert Janssen, Kees Jalink, Arno Floore, Arno Velds, Laura van 't Veer, Jacques Neefjes

Izdano 2004

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
16

N-ras mutations in human cutaneous melanoma from sun-exposed body sites. od Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

Izdano 1989

Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
17

A protocol for building and evaluating predictors of disease state based on microarray data od Lodewyk F.A. Wessels, Marcel J. T. Reinders, A.A.M. Hart, Cor J. Veenman, H. Dai, Yudong D. He, Laura van ‘t Veer

Izdano 2005

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
18

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients od James M. Ford, Sophie Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van ’t Veer

Izdano 2017

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
19

A combined oncogenic pathway signature ofBRAF,KRASandPI3KCAmutation improves colorectal cancer classification and cetuximab treatment prediction od Sun Tian, Iris Simón, Vı́ctor Moreno, Paul Roepman, Josep Tabernero, Mireille H.J. Snel, Laura van’t Veer, Ramón Salazar, René Bernards, Gabriel Capellà

Izdano 2012

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
20

Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes od Mahasti Saghatchian, Stella Mook, Giancarlo Pruneri, Giuseppe Viale, Annuska M. Glas, Sylvie Guérin, Fátima Cardoso, Martine Piccart, Thomas Tursz, Suzette Delaloge, Laura van’t Veer

Izdano 2013

Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:

Rezultati - Laura Van't Veer

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays od Kathy S. Albain, Soonmyung Paik, Laura van’t Veer

The MINDACT trial: The first prospective clinical validation of a genomic tool od Fátima Cardoso, Martine Piccart, Laura Van't Veer, Emiel J. Rutgers

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary od John Bridgewater, Ryan K. van Laar, Arno Floore, Laura van’t Veer

Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity od Denise M. Wolf, Marc E. Lenburg, Christina Yau, Aaron Boudreau, Laura van ‘t Veer

Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma od Patti Curl, Igor Vujic, Laura van ‘t Veer, Susana Ortiz‐Urda, James G. Kahn

TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. od Guus Hateboer, H. T. Marc Timmers, AK Rustgi, Marc Billaud, Laura van ‘t Veer, René Bernards

E2F-5, a New E2F Family Member That Interacts with p130 In Vivo od E. Marielle Hijmans, P. Mathijs Voorhoeve, Roderick L. Beijersbergen, Laura van ‘t Veer, René Bernards

Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability od Josien C.C. Scheepens, Laura van ‘t Veer, Laura J. Esserman, Jeffrey Belkora, Rita A. Mukhtar

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance od Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura van ‘t Veer, Mark Jesus M. Magbanua

Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. od Mark J. Alkema, Marieke Bronk, Els Verhoeven, Arie P. Otte, Laura van ‘t Veer, A Berns, Maarten van Lohuizen

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature od Michael Knauer, Fátima Cardoso, Jelle Wesseling, Philippe L. Bédard, Sabine C. Linn, Emiel J. Rutgers, Laura van ‘t Veer

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis od Alexandra J. van den Broek, Marjanka K. Schmidt, Laura van ‘t Veer, Rob A.�E.�M. Tollenaar, Flora E. van Leeuwen

Comparison of prognostic gene expression signatures for breast cancer od Benjamin Haibe‐Kains, Christine Desmedt, Fanny Piette, Marc Buyse, Fátima Cardoso, Laura van’t Veer, Martine Piccart, Gianluca Bontempi, Christos Sotiriou

Expression profiling predicts outcome in breast cancer od Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver, Yudong D. He, Augustinus A. M. Hart, René Bernards, Stephen Friend

Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer od Rob Michalides, Alexander Griekspoor, Astrid Balkenende, Desirée Verwoerd, Lennert Janssen, Kees Jalink, Arno Floore, Arno Velds, Laura van 't Veer, Jacques Neefjes

N-ras mutations in human cutaneous melanoma from sun-exposed body sites. od Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

A protocol for building and evaluating predictors of disease state based on microarray data od Lodewyk F.A. Wessels, Marcel J. T. Reinders, A.A.M. Hart, Cor J. Veenman, H. Dai, Yudong D. He, Laura van ‘t Veer

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients od James M. Ford, Sophie Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van ’t Veer

Iskalna orodja:

Sorodne teme